Skip to content

Clinical trials

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Country / region: China Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20202
20244
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Active, not recruiting1
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tongji Hospital3
Beijing Tiantan Hospital1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1
Third Affiliated Hospital, Sun Yat-Sen University1
Tianjin Medical University General Hospital1
Xuanwu Hospital, Beijing1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease8
Multiple Sclerosis7
Neuromyelitis Optica7
Autoimmune Diseases of the Nervous System4
Myasthenia Gravis4
Encephalomyelitis, Acute Disseminated3
Guillain-Barre Syndrome2
Myositis2
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating2
Autoimmune Diseases1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.